Save
OCT in CIS and early MS
ECTRIMS Online Library, Benjamin Knier, 219502
OCT in later stages and progressive MS
ECTRIMS Online Library, Elena Martinez-Lapiscina, 219503
OCT and MRI
ECTRIMS Online Library, Peter Calabresi, 219504
OCT and body fluid markers (biomarkers from blood, CSF; genetics)
ECTRIMS Online Library, Axel Petzold, 219505
OCT and disease modifying therapies
ECTRIMS Online Library, Shiv Saidha, 219506
NMO
ECTRIMS Online Library, Olivier Outteryck, 219507
MOG-EM
ECTRIMS Online Library, Friedemann Paul, 219508
Susac’s syndrome
ECTRIMS Online Library, Alexander U. Brandt, 219509
OCT outside MS: Aging, Parkinson’s disease, Huntington’s disease
ECTRIMS Online Library, Philipp Albrecht, 219510
Optic neuritis during MS (time course, findings, prognostic impact)
ECTRIMS Online Library, Fiona Costello, 219498
Functional impact of retinal damage (impact on LCLA, color vision, QOL, motion perception)
ECTRIMS Online Library, Laura Balcer, 219499
OCT as outcome measure in optic neuritis trials
ECTRIMS Online Library, Wolf Lagrèze, 219500
OCT as outcome measure in multiple sclerosis trials
ECTRIMS Online Library, Ari Green, 219501
Assessing visual function in clinical practice
ECTRIMS Online Library, Netta Levin, 219490
Technique, methodological limitations, different OCT applications / brands
ECTRIMS Online Library, Gábor Mark Somfai, 219491
Factors influencing OCT parameters (e.g. eye diseases) including quality control and quality criteria
ECTRIMS Online Library, Lisanne Balk, 219492
Retinal segmentation
ECTRIMS Online Library, Hanna G. Zimmermann, 219493
OCT angiography
ECTRIMS Online Library, Gabriella Szatmáry, 219494
Murine and rat OCT
ECTRIMS Online Library, Sven Schippling, 219495
Two-photon excitation microscopy
ECTRIMS Online Library, Alexander U. Brandt, 219496
Opening remarks
ECTRIMS Online Library, Amit Bar-Or, 202634
Auto-antibodies in demyelinating CNS diseases
ECTRIMS Online Library, Palace Jacqueline, 202635
The spectrum of auto-antibodies in autoimmune encephalitis
ECTRIMS Online Library, Marteen Titulaer, 202636
Open round table discussion
ECTRIMS Online Library, Amit Bar-Or, 202637
Pathogenic mechanisms of human autoantibodies against myelin oligodendrocyte glycoprotein
ECTRIMS Online Library, Edgar Meinl, 202638
The primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI
ECTRIMS Online Library, Daniel Reich, 202639
PARADIGMS: a randomised double-blind study of fingolimod versus interferon β-1a in paediatric multiple sclerosis
ECTRIMS Online Library, Tanuja Chitnis, 202640
Blood NfL as a potential endpoint in Phase 2 clinical studies in relapsing-remitting multiple sclerosis
ECTRIMS Online Library, Maria Pia Sormani, 202641
SPRINT-MS/NN 102 phase II trial of ibudilast in progressive MS: top-line results
ECTRIMS Online Library, Robert J. Fox, 202642
Week 24 results from a Phase IIb trial of GNbAC1 in patients with relapsing remitting multiple sclerosis (CHANGE-MS; Clinical trial assessing the HERV-W Env antagonist GNbAC1 for Efficacy in MS)
ECTRIMS Online Library, Hans-Peter Hartung, 202643
Ozanimod vs interferon β-1a: clinical and MRI results of RADIANCE part B - A 2-year Phase 3 trial in relapsing multiple sclerosis
ECTRIMS Online Library, Jeffrey A. Cohen, 202644
Charcot Lecture: Management of suboptimal therapeutic response in MS
ECTRIMS Online Library, Per Soelberg-Sorensen, 202645
Clinical highlights
ECTRIMS Online Library, Alasdair J. Coles, 202646
Clinical highlights
ECTRIMS Online Library, Robert J. Fox, 202647
Scientific highlights
ECTRIMS Online Library, Ari Green, 202648
Scientific highlights
ECTRIMS Online Library, David Laplaud, 202649
Welcome to Berlin
ECTRIMS Online Library, , 202650
Satellite Symposium (full symposium) - Turning the lights on: seeing is believing
ECTRIMS Online Library, Martin Duddy, Jiwon Oh & James Overell, 203354
01 Welcome & Introduction V1
ECTRIMS Online Library, Martin Duddy, 203355
02 Toward an evolving understanding of MS as a progressing disease V1
ECTRIMS Online Library, Martin Duddy, 203356
03 Panel discussion V1
ECTRIMS Online Library, Martin Duddy, Jiwon Oh & James Overell, 203357
04 Patient cases: the manifold faces of progression across the MS continuum V1
ECTRIMS Online Library, James Overell, 203358
05 MS Continuum V1
ECTRIMS Online Library, Martin Duddy, 203359
Enhanced regional cerebral perfusion following acetazolamide: preliminary results
ECTRIMS Online Library, John Lincoln, 199871
[F-18]PBR06 PET to assess TSPO binding and its association with brain atrophy and disability in multiple sclerosis
ECTRIMS Online Library, Tarun Singhal, 199872
Elevated adiponectin levels induce pro-inflammatory myeloid- and T-cell responses linking adiposity and predisposition to pediatric MS
ECTRIMS Online Library, Giulia Fadda, 199873
Big Multiple Sclerosis Data Network: impact of early treatment on long term disability accumulation in relapsing remitting multiple sclerosis patients
ECTRIMS Online Library, Pietro Iaffaldano, 199874
Cesarean delivery and artificial lactation are associated with an earlier age of disease onset in multiple sclerosis
ECTRIMS Online Library, Gloria Dalla Costa, 199875
Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed multiple sclerosis
ECTRIMS Online Library, Finn Sellebjerg, 199876
Ozanimod demonstrates preservation of brain volume at 1 and 2 years in two Phase 3 trials of relapsing multiple sclerosis (SUNBEAM and RADIANCE)
ECTRIMS Online Library, Douglas L. Arnold, 199877
Optic nerve involvement for establishing dissemination in space: is it worth assessing the visual pathway with VEP?
ECTRIMS Online Library, Àngela Vidal-Jordana, 199878
Long term disease progression in disease activity-free relapsing MS
ECTRIMS Online Library, Bruce A.C. Cree, 199879
ATL1102 treatment reduces conversion of active multiple sclerosis lesions into persistent black holes
ECTRIMS Online Library, Frederik Barkhof, 199880
Prognostic value of MRI activity in treatment failure
ECTRIMS Online Library, Amy Kunchok, 199881
Sativex® as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity double blind randomized clinical trial
ECTRIMS Online Library, Jolana Markova, 199882
Lipocalin-2 is upregulated in reactive astrocytes in neuromyelitis optica
ECTRIMS Online Library, Sunjae Hwang, 199883
Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial
ECTRIMS Online Library, Vahid Shaygannejad, 199884
Comorbidity increases the risk of relapse in multiple sclerosis: a prospective study
ECTRIMS Online Library, Kaarina Kowalec, 199885
Centrifugal pattern of progressive water diffusion increase in chronic MS lesions
ECTRIMS Online Library, Chenyu Wang, 199886
The risk of relapse following on-treatment clinically silent lesions in patients with relapsing-remitting multiple sclerosis
ECTRIMS Online Library, J William L Brown, 199887
Oligoclonal immunoglobulin gamma bands in the cerebrospinal fluid confers higher risk to reach EDSS milestones and to convert to secondary progression
ECTRIMS Online Library, Virginija Danylaite Karrenbauer, 199888
Can the BBB be targeted for treatment of MS? Evidence that IL-6 is actively transported across the BBB in vivo by an IL-6 specific transporter reveals a novel target linked to inflammatory immunity
ECTRIMS Online Library, Su Metcalfe, 199889
Exome sequencing in multiple sclerosis families defines biological pathways for patients with primary progressive and relapsing remitting disease course
ECTRIMS Online Library, Carles Vilarino-Guell, 199890
A behavioral test to evaluate the funtional consequences in a Xenopus laevis model of inducible-demyelination and myelin repair
ECTRIMS Online Library, Bernard Zalc, 199891
Quercetin enhances myelin repair and ameliorated astrocytes activation in lysolecithin-induced focal demyelination
ECTRIMS Online Library, Maryam Ghasemi-Kasman, 199892
"Taste", a pilot study: Palatability and oral cavity tolerability of Sativex and possible improvement measures in multiple sclerosis patients with resistant spasticity
ECTRIMS Online Library, Giacomo Lus, 199893
Pregnancy outcomes during the clinical development programme of cladribine in multiple sclerosis (MS): an integrated analysis of safety for all exposed patients
ECTRIMS Online Library, Vicky John, 199894
Development of a new chronic model of T cell-driven CNS autoimmunity
ECTRIMS Online Library, Manu Rangachari, 199895
Histopathological features of “cavitary” or “cystic” multiple sclerosis (MS) compared to classical MS
ECTRIMS Online Library, Erik Bahn, 199896
The effect of alemtuzumab on periventricular magnetisation transfer ratio gradients
ECTRIMS Online Library, J William L Brown, 199897
An analysis of malignancy risk in the clinical development programme of cladribine tablets in patients with relapsing multiple sclerosis (RMS)
ECTRIMS Online Library, Vicky John, 199898
Long-term efficacy and safety of fingolimod in patients with RRMS: 10-year experience from LONGTERMS study
ECTRIMS Online Library, Jeffrey A. Cohen, 199899
Examining the role of MS-associated genetic risk factors in a humanized mouse model of Epstein-Barr virus infection
ECTRIMS Online Library, Hana Zdimerova, 199900
Switching to alemtuzumab from fingolimod or other therapies: impact of wash-out period on disease activity
ECTRIMS Online Library, Jessica Frau, 199901
Clinical, demographic and laboratory data associated with PML risk in patients treated with natalizumab
ECTRIMS Online Library, Luisa Maria Villar, 199902
Multiple sclerosis associated cytotoxic CD4+ T cells escape regulatory T cell mediated suppression
ECTRIMS Online Library, Niels Hellings, 199903
Vitamin D levels in a multiple sclerosis population treated with rituximab
ECTRIMS Online Library, Peter Sundström, 199904
Short-term memory loss correlates with mean diffusivity and free-water in recently diagnosed multiple sclerosis patients
ECTRIMS Online Library, Ørjan Bergmann, 199905
An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis
ECTRIMS Online Library, Jonathan Cho, 199906
Advanced imaging detects variations in myelin content and thickness in the corpus callosum of neuromyelitis optica patients and healthy controls
ECTRIMS Online Library, Shawna Abel, 199907
Corpus callosum atrophy in MS is halted by autologous haematopoietic stem cell transplantation
ECTRIMS Online Library, Andreas Tolf, 199908
Epstein-Barr virus induced G-protein coupled receptor 2 (GPR 183) in B lymphocyte can be associated with the relapse of neuromyelitis optica spectrum disorder with AQP4-IgG
ECTRIMS Online Library, Sung-Min Kim, 199909
Comparison of skin cell immunity in patients receiving treatment with gilenya (fingolimod) and healthy controls
ECTRIMS Online Library, Stephen Newman, 199910
Comparative effectiveness of dimethyl fumarate, teriflunomide, interferon-beta and glatiramer acetate on newly diagnosed patients: a propensity score-matched analysis from a multicenter Italian group
ECTRIMS Online Library, Alessio Signori, 199911
Repeated administrations of macrocyclic gadolinium based contrast agents do not cause increased signal intensity in dentate nucleus and globus pallidus on T1-weighted unenhanced magnetic resonance images: confirmed safety in multiple sclerosis
ECTRIMS Online Library, Arianna Sartori, 199912
Flowy cytometric assay for antibody to myelin oligodendrocyte glycoprotein in chronic relapsing inflammatory optic neuropathy (CRION)
ECTRIMS Online Library, Boram Kim, 199913
What is the best home-based walking exercise prescription for people with multiple sclerosis? A randomized controlled clinical trial
ECTRIMS Online Library, Najaf Aghaei, 199914
[F-18]PBR06 vs. [C-11]PBR28 PET for assessing white matter TSPO binding in multiple sclerosis
ECTRIMS Online Library, Tarun Singhal, 199915
Cladribine controls multiple sclerosis via memory B cell depletion
ECTRIMS Online Library, Bryan Ceronie, 199916
Pro-inflammatory monocyte subsets are augmented in incipient and progressed multiple sclerosis
ECTRIMS Online Library, Mikkel Carstensen Gjelstrup, 199917
THC: CBD (Nabiximols) has a beneficial effect on resistant MS related spasticity and reduces the need for Intrathecal baclofen
ECTRIMS Online Library, Stefania De Trane, 199918
Glatiramer acetate depot (extended-release) phase IIa one-year study in patients with relapsing remitting multiple sclerosis: safety, tolerability and efficacy (no evidence of disease activity) analysis
ECTRIMS Online Library, Ariel Miller, 199919
Online personalized education improves overall knowledge of multiple sclerosis in neurologists
ECTRIMS Online Library, Thomas Finnegan, 199920
Risk-benefit assessment of natalizumab therapy in multiple sclerosis patients and their treating physicians
ECTRIMS Online Library, Julia Krämer, 199921
Basic immunological profile changes with BAF312 (siponimod) treatment in secondary progressive multiple sclerosis patients
ECTRIMS Online Library, Yang Mao-Draayer, 199922
Effect of eight weeks DNS exercises quality of life and function in women with multiple sclerosis
ECTRIMS Online Library, Saeid Shahbeigi, 199923
IgG from multiple sclerosis patients positive for antiphospholipid antibodies increases the activation of p38 MAPK and p65 NF-κB
ECTRIMS Online Library, Marios Pantzaris, 199924
Oncostatin M and the inflamed blood brain barrier: good, bad or both?
ECTRIMS Online Library, Niels Hellings, 199925
Serum NF-L in NMOSD and related disorders: comparison according to AQP4 and MOG antibodies status
ECTRIMS Online Library, Sara Mariotto, 199926
Cortical grey matter ratio differentiates relapsing remitting multiple sclerosis from secondary progressive multiple sclerosis
ECTRIMS Online Library, Jeroen Fleer, 199927

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings